Literature DB >> 24092614

Epigenetics and psychiatry.

Melissa Mahgoub1, Lisa M Monteggia.   

Abstract

Psychiatric disorders including major depressive disorder, drug addiction, and schizophrenia are debilitating illnesses with a multitude of complex symptoms underlying each of these disorders. In recent years, it has become appreciated that the onset and development of these disorders goes beyond the one gene-one disease approach. Rather, the involvement of many genes is likely linked to these illnesses, and regulating the activation or silencing of gene function may play a crucial role in contributing to their pathophysiology. Epigenetic modifications such as histone acetylation and deacetylation, as well as DNA methylation can induce lasting and stable changes in gene expression, and have therefore been implicated in promoting the adaptive behavioral and neuronal changes that accompany each of these illnesses. In this review we will discuss some of the latest work implicating a potential role for epigenetics in psychiatric disorders, namely, depression, addiction, and schizophrenia as well as a possible role in treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24092614      PMCID: PMC3805856          DOI: 10.1007/s13311-013-0213-6

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  73 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

Review 2.  Epigenetics: a landscape takes shape.

Authors:  Aaron D Goldberg; C David Allis; Emily Bernstein
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

3.  Covalent modification of DNA regulates memory formation.

Authors:  Courtney A Miller; J David Sweatt
Journal:  Neuron       Date:  2007-03-15       Impact factor: 17.173

Review 4.  The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity.

Authors:  Eero Castrén; Tomi Rantamäki
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

5.  CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum.

Authors:  Amir A Levine; Zhonghui Guan; Angel Barco; Shiqin Xu; Eric R Kandel; James H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-27       Impact factor: 11.205

6.  Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving.

Authors:  Jeffrey W Grimm; Lin Lu; Teruo Hayashi; Bruce T Hope; Tsung-Ping Su; Yavin Shaham
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

7.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

8.  Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse.

Authors:  Danielle L Graham; Scott Edwards; Ryan K Bachtell; Ralph J DiLeone; Maribel Rios; David W Self
Journal:  Nat Neurosci       Date:  2007-07-08       Impact factor: 24.884

9.  On the epigenetic regulation of the human reelin promoter.

Authors:  Ying Chen; Rajiv P Sharma; Robert H Costa; Erminio Costa; Dennis R Grayson
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

Review 10.  The molecular genetics of schizophrenia: new findings promise new insights.

Authors:  M J Owen; N M Williams; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2004-01       Impact factor: 15.992

View more
  27 in total

1.  Looking above but not beyond the genome for therapeutics in neurology and psychiatry: epigenetic proteins and RNAs find a new focus.

Authors:  Manuela Basso; Sama Sleiman; Rajiv R Ratan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

2.  Risk factors for obsessive-compulsive symptoms. Follow-up of a community-based youth cohort.

Authors:  Pedro Macul Ferreira de Barros; Maria Conceição do Rosário; Natalia Szejko; Natália Polga; Guaraci de Lima Requena; Beatriz Ravagnani; Daniel Fatori; Marcelo Camargo Batistuzzo; Marcelo Queiroz Hoexter; Luis Augusto Rohde; Guilherme Vanoni Polanczyk; James Frederick Leckman; Eurípedes Constantino Miguel; Pedro Gomes de Alvarenga
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-02-19       Impact factor: 4.785

3.  Neuronal Deletion of Kmt2a/Mll1 Histone Methyltransferase in Ventral Striatum is Associated with Defective Spike-Timing-Dependent Striatal Synaptic Plasticity, Altered Response to Dopaminergic Drugs, and Increased Anxiety.

Authors:  Erica Y Shen; Yan Jiang; Behnam Javidfar; Bibi Kassim; Yong-Hwee E Loh; Qi Ma; Amanda C Mitchell; Venu Pothula; A Francis Stewart; Patricia Ernst; Wei-Dong Yao; Gilles Martin; Li Shen; Mira Jakovcevski; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2016-08-03       Impact factor: 7.853

Review 4.  The gut microbiome and the brain.

Authors:  Leo Galland
Journal:  J Med Food       Date:  2014-12       Impact factor: 2.786

Review 5.  A translational perspective on histone acetylation modulators in psychiatric disorders.

Authors:  Surajit Ganguly; Subhendu Seth
Journal:  Psychopharmacology (Berl)       Date:  2018-06-19       Impact factor: 4.530

6.  CB1R regulates CDK5 signaling and epigenetically controls Rac1 expression contributing to neurobehavioral abnormalities in mice postnatally exposed to ethanol.

Authors:  Vikram Joshi; Shivakumar Subbanna; Madhu Shivakumar; Balapal S Basavarajappa
Journal:  Neuropsychopharmacology       Date:  2018-08-22       Impact factor: 7.853

7.  HDAC inhibitor-dependent transcriptome and memory reinstatement in cognitive decline models.

Authors:  Eva Benito; Hendrik Urbanke; Binu Ramachandran; Jonas Barth; Rashi Halder; Ankit Awasthi; Gaurav Jain; Vincenzo Capece; Susanne Burkhardt; Magdalena Navarro-Sala; Sankari Nagarajan; Anna-Lena Schütz; Steven A Johnsen; Stefan Bonn; Reinhardt Lührmann; Camin Dean; André Fischer
Journal:  J Clin Invest       Date:  2015-08-17       Impact factor: 14.808

Review 8.  Bile Acids: A Communication Channel in the Gut-Brain Axis.

Authors:  Vera F Monteiro-Cardoso; Maria Corlianò; Roshni R Singaraja
Journal:  Neuromolecular Med       Date:  2020-10-21       Impact factor: 3.843

Review 9.  Transcriptional and epigenetic mechanisms of early cortical development: An examination of how Pax6 coordinates cortical development.

Authors:  Athéna R Ypsilanti; John L R Rubenstein
Journal:  J Comp Neurol       Date:  2015-08-25       Impact factor: 3.215

10.  Ketamine produces antidepressant-like effects through phosphorylation-dependent nuclear export of histone deacetylase 5 (HDAC5) in rats.

Authors:  Miyeon Choi; Seung Hoon Lee; Sung Eun Wang; Seung Yeon Ko; Mihee Song; June-Seek Choi; Yong-Seok Kim; Ronald S Duman; Hyeon Son
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.